Industry Roundup: GNC, Sanofi And Bayer Earnings, 'Miracle Supplement' Fraud Conviction
This article was originally published in The Tan Sheet
Executive Summary
GNC CEO slams Oregon charges; Allegra, Nasacort key for Sanofi consumer; Consumer boosts Bayer; 'Miracle Supplement' seller sentenced; and more news in brief.
You may also be interested in...
Autism 'Cure' Products Spur Comment Wave On FDA's VMS Industry Oversight
More than half the 73 comments posted to FDA's DSHEA modernization docket are from consumers concerned about a specific type of product, bleach-containing liquids marketed as a cure for autism.
Health & Wellness Industry Roundup: July 11-15
Compromise GMO legislation passes House; private equity looks for health, wellness investments, including China; and more news in brief.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.